Insomnia Clinical Trial
Official title:
Combined Electroacupuncture and Auricular Acupuncture for Persistent Insomnia: A Randomized Controlled Trial of Dose-Response Effect
This is a randomized controlled trial to evaluate the clinical efficacy of combined electro-acupuncture and auricular acupuncture for persistent Iinsomnia in the adult population in Hong Kong.
Status | Recruiting |
Enrollment | 224 |
Est. completion date | December 2015 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Aged 18 years or above - Hong Kong residents - Ethnic Chinese - Meet the diagnosis criteria of presistent insomnia for at least 3 months according to Current Diagnostic and Statistical Manual of Mental Disorders (the proposed Fifth Edition) - Insomnia more than 3 nights per week for at least 3 months - Willing to give informed consent - Able to comply with trial protocol Exclusion Criteria: - Have a Hamilton Depression Rating Scale scores above 18 - Have sleep apnea or periodic limbs movement disorder detected by overnight polysomnography - Have suicidal risk as assessed by the Hamilton Depression Rating Scale suicidal risk item - Have current major depressive disorder, generalized anxiety disorders or panic disorder, manic or hypomanic episode, substance use disorders except caffeine and nicotine, organic mental disorder, schizophrenia or any other psychotic disorder - Receiving psychotropic drugs with dosage changes in the last 4 weeks prior to screening, baseline or during the study - Have valvular heart defects or bleeding disorders or were taking anticoagulant drugs - Are pregnant, breast-feeding, or woman of childbearing potential not using adequate contraception - Have any unstable psychiatric conditions or serious physical illnesses which are judged by the investigator to render unsuitable or unsafe - Have infection or abscess close to the site of selected acupoints and in the investigator's opinion inclusion is unsafe - Taking Chinese herbal medicine or over-the-counter drugs which are intending for insomnia within the last 2 weeks prior to baseline or during the study - Any acupuncture or auricular acupuncture treatment during the previous 6 months prior to baseline |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Hong Kong | Queen Mary Hospital | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong | Hong Kong Baptist University |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of sleep parameters by subjective measures using sleep log | We will measure sleep parameters (including sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by subjective measures using sleep log. The measure is a composite outcome measure consisting of multiple measures | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No |
Secondary | Change of self-rated sleep quality score measured by Insomnia Severity Index (ISI) questionnaire | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of self-rated sleep quality score measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaire | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of anxiety and depression states measured by Hospital Anxiety and Depression Scale (HADS) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' functioning regarding work/study, social life and family measured by Sheehan Disability Scale (SDS) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' self-rated fatigue score measured by Multidimensional Fatigue Inventory (MFI) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' likeliness of dozing measured by Epworth Sleepiness Scale (ESS) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' sleep-related cognition measured by Dysfunctional Beliefs and Attitudes about Sleep (DBAS) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' sleep inhibitory behaviors measured by Sleep Hygiene Practice Scale (SHPS) | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of subjects' credibility to the treatment measured by Credibility of treatment rating scale | Second and the last time of the treatment; 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of sleep parameters (sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep) by objective measure - wrist actigraphy | Sleep parameters include sleep onset latency, sleep efficiency, total sleep time, times of wakening during sleep. The measure is a composite outcome measure consisting of multiple measures | Baseline, 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No |
Secondary | Change of serious adverse events measured by Serious Adverse Event (SAE) | 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No | |
Secondary | Change of potential adverse events related to acupuncture measured by Adverse Events Report Related to Acupuncture | 1-week posttreatment, 4-week posttreatment, and 13-week posttreatment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A |